LS 4559 P
Alternative Names: LS 4559P; LS 4577Latest Information Update: 10 Sep 1998
At a glance
- Originator Pharmacia Corporation
- Class Antineoplastics; Phenyl ethers; Small molecules
- Mechanism of Action Tubulin inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 10 Sep 1998 Profile reviewed
- 10 Sep 1998 No-Development-Reported for Cancer in Sweden (Unknown route)
- 02 Oct 1996 Preclinical development for Cancer in Sweden (Unknown route)